BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17412521)

  • 1. [Dynamic circadian system patients under chimiotherapy].
    Beau J; Iurisci I; Beau T; Lévi F
    Pathol Biol (Paris); 2007; 55(3-4):171-5. PubMed ID: 17412521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
    Lévi F
    Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chronotherapy: a drug delivery challenge.
    Hrushesky WJ
    Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.
    Clairambault J
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1054-68. PubMed ID: 17707544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological perspectives on circadian cancer therapy.
    Wood PA; Hrushesky WJ
    J Infus Chemother; 1995; 5(4):182-90. PubMed ID: 8934723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of circadian rhythms by actimetry in healthy subjects and patients with advanced colorectal cancer.
    Chevalier V; Mormont MC; Curé H; Chollet P
    Oncol Rep; 2003; 10(3):733-7. PubMed ID: 12684651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotherapeutics: the relevance of timing in cancer therapy.
    Lévi F
    Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian timing in cancer treatments.
    Lévi F; Okyar A; Dulong S; Innominato PF; Clairambault J
    Annu Rev Pharmacol Toxicol; 2010; 50():377-421. PubMed ID: 20055686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronochemotherapy for cancer].
    Akazawa S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian rhythm of wrist temperature in normal-living subjects A candidate of new index of the circadian system.
    Sarabia JA; Rol MA; Mendiola P; Madrid JA
    Physiol Behav; 2008 Nov; 95(4):570-80. PubMed ID: 18761026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients.
    Pati AK; Parganiha A; Kar A; Soni R; Roy S; Choudhary V
    Chronobiol Int; 2007; 24(6):1179-97. PubMed ID: 18075806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circadian timing system in clinical oncology.
    Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
    Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronobiology and cancer].
    Lévi F
    Pathol Biol (Paris); 1987 Jun; 35(6):960-8. PubMed ID: 3306577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the amplitude dynamics of the human core-temperature circadian rhythm using a stochastic-dynamic model.
    Indic P; Brown EN
    J Theor Biol; 2006 Apr; 239(4):499-506. PubMed ID: 16223510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational modeling of synchronization process of the circadian timing system of mammals.
    Cardoso FR; de Oliveira Cruz FA; Silva D; Cortez CM
    Biol Cybern; 2009 May; 100(5):385-93. PubMed ID: 19367410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
    Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
    Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell cycle automaton model for probing circadian patterns of anticancer drug delivery.
    Altinok A; Lévi F; Goldbeter A
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1036-53. PubMed ID: 17692993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics.
    Lévi F; Okyar A
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1535-41. PubMed ID: 22097903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circadian timing system: a coordinator of life processes: chronobiological investigations. Implications for the rhythmic delivery of cancer therapeutics.
    Lévi FA
    IEEE Eng Med Biol Mag; 2008; 27(1):17-9. PubMed ID: 18270045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.